• Diagnosis​ Info ​and​ ​General​ ​Questions

  GBT and Syros Partner to Develop Sickle Cell Treatments That Boost Fetal Hemoglobin

  Posted by Sickle Cell Forum Administrator on February 4, 2020 at 7:12 pm

  

  Syros will use its gene control platform to ID drugs stimulating fetal hemoglobin production; Global Blood Therapeutics will develop and market the results. Learn more about this project here.

  What do you think about this project?

  Sickle Cell Forum Administrator replied 4 years, 2 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply